Hepatitis C Virus Cascade of Care in Florida Emergency Departments
Pilar Hernandez-Con, Suk-Chan Jang, Steven M. Smith, Chanakan Jenjai, Faheem Guirgis, Michael C. Petrauskis, Christine Gage, Haesuk ParkBackground:
Florida has the second-highest rate of acute hepatitis C virus (HCV) infection cases in the United States. However, HCV care cascade outcomes among individuals seeking care in Florida emergency departments (EDs) remain unknown.
Objectives:
To assess HCV care cascade outcomes and identify HCV infection predictors among individuals tested for HCV in Florida EDs.
Research Study Design:
This retrospective study used electronic health records (2016–2023) linked to the Agency for Healthcare Research and Quality on Social Determinants of Health regional data.
Subjects:
Adults aged 18–79 years tested for HCV infection in Florida EDs.
Measures:
Outcomes included the proportions of individuals completing each HCV care cascade step: (1) HCV screening; (2) HCV diagnosis; (3) linkage to care; and (4) treatment initiation. A multivariable logistic regression model was used to identify predictors of HCV infection.
Results:
Among individuals seeking care in EDs, 4.98% (n=18,444) were tested for HCV, of whom 4.97% were confirmed HCV-positive. Among HCV-positive individuals, 11.24% were linked to care, and 2.84% initiated treatment. Significant predictors of HCV infection included having Medicaid insurance (OR=1.53, 95% CI: 1.14–2.07) or being uninsured (OR=2.88, 95% CI: 2.02–4.12), coinfection with human immunodeficiency virus (OR=28.99, 95% CI: 22.31–37.67), opioid injection drug use (OR=3.62, 95% CI: 2.76–4.75), opioid overdose (OR=3.89, 95% CI: 2.32–6.52), and residing in communities characterized by lower educational attainment (fourth quartile OR=1.95, 95% CI: 1.27–2.98).
Conclusions:
Significant gaps persist across the HCV care cascade among individuals tested in Florida EDs. Innovative public health interventions are needed to support these vulnerable populations.